91
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Isolated Anti-HBc Among HIV-Infected Patients in Istanbul, Turkey

, &
Pages 17-20 | Published online: 06 Jan 2015

REFERENCES

  • Centers for Disease Control and Prevention. Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recom-mendations for postexposure prophylaxis. MMWR Rec Rep. 200150: 1–42.
  • Jindal N, Arora U, Singh K. Prevalence of human immunodeficiency virus, HBV, HCV in three groups of populations at high risk of HIV Infection in Amristar, North-ern India. Jpn J Infect Dis. 2008;61:79–81.
  • Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immuno-deficiency virus: the D:A:D study. Arch Intern Med. 2006;166(15)1 632–1641.
  • Rockstroh JK. Management of hepatitis B and C in HIV coinfected patients. J Acquir Immune Defic Syndr. 2003;34:59–65.
  • Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S. Serological pattern “anti HBc alone”: report on a work-shop. J Med ViroL 62:450–455.
  • Berger A, Doerr HW, Rabenau HF, Weber B. High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Intervirology. 2000;44:71–76.
  • Bukhtiari N, Hussain T, Lqbal M, Malik AM, Qureshi AH, Hussian A. Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pat-tern. J Pak Med Assoc. 2003;53:136–140.
  • Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Pater-lini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically sig-nificant or purely "occult"? Hepatology. 2001;34: 194–203.
  • Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B infection. J HepatoL 2007;46:160–170.
  • Toy M, Onder FO, Wormann T, Bozdayi AM, Schalm SW. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a sys-tematic review. BMC Infect Dis. 2011;11:337.
  • Santos EA, Yoshida CF, Rolla VC, et al. Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis. 2003;22:92–98.
  • Piroth L, Binquet C, Vergne M, et al. The evolution of hepa-titis of hepatitis B virus serological patterrns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J HepatoL 2002;36:681–686.
  • Osborn MK, Guest JL, Rimland D. Hepatitis B and HIV coinfection: relation of different serological patterns to survival and liver disease. HIV Med. 2007;8:271–279.
  • French AL, Operskkalski E, Peters M, et al. Isolated hepati-tis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis. 2007;195:1437–1442.
  • Perez-Rodriguez MT, Sopena B, Crespo M, et al. Clinical significance of "anti-HBc alone" in human immunode-ficiency virus-positive patients. World J Gastroenterol. 2009;15:1237–1242.
  • Firnhaber C, Viana R, Reyneke A, et al. Occult hepatitis B virus infections in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesbug, South Africa. Int J Infect Dis. 2009;13:488–492.
  • Remazani A, Banifazi M, Eslamifar A, Aghakhani A. Sero-logical pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010;4:658–661.
  • Colomina-Rodrfguez J, González-Garcfa D, Burgos-Teruel A, Fernández-Lorenz N, Guerrero-Espejo A. Significance of hepatitis core antibody as the only marker of hepatitis. Enferm lnfecc Microbiol Clin. 2005;23:80–85.
  • Altunay H, Kosan E, Birinci, Aksoy A, Kirali K. Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination. Transfus Apher ScL 2010;43:265–268.
  • Kaye S, Kesbic H, Alanoglu G, Aridogan BC, Cetin ES, Tas T, Demirci M. The investigation of isolated hepatitis B virus core antibodies in blood donors. Nobel Medicus. 2009;5:17–21.
  • Yildirim B, Barut S, Bulut Y, Yenigehirli G, Ozdemir M. Sero-prevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: a population-based study. Turk J GastroenteroL 2009;20:27–30.
  • Shire NJ, Rouster SD, Rajicic N, Sherman KE. Occult hepatitis B in HIV-infected patients. J Acquire Immune Defic Syndr. 2004;36:869–875.
  • Hofer M, Joller-Jemelka HI, Grob PJ, Lathy R, Opravil M. Frequent chonic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis. 1998;17:6–13.
  • Gandhi RT, Wurcel A, Lee H, et al. Isolated antibody to hepa-titis B core antigen in human immunodeficiency vius type-1 infected individuals. Clin Infect Dis. 2003;36:1602–1605.
  • Gupta S, Singh S. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in North India. BMC Infect Dis. 2010;10:53.
  • Neau D, Winnock M, Galperine T, et al. Isolated antibodi-est against the core antigen of hepatitis B in HIV-infected patinets. HIV Med. 2004;5:171–173.
  • Liang SH, Chen TJ, Lee SS, et al. Risk factors of isolated antibody against core antigen of hepatitis B virus: asso-ciation with HIV infection and age but not hepatitis C virus infection. J Acquire Immune Defic Syndr. 2010:54;122–128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.